Project leader |
Project leader in Switzerland: Prof. Alice Panchaud (BIHAM) |
|
Project team |
Prof. Alice Panchaud (BIHAM), Prof David Baud (CHUV), Dr Emeline Maisonneuve (BIHAM), Dr Guillaume Favre (CHUV) |
|
Doctoral student(s) |
Dr. Emeline Maisonneuve (BIHAM) |
|
Partner(s) |
Lead of European project: Pharmacovigilance Center in Lareb and the University Medical Center Utrecht in the Netherlands
Partners: Rotunda Hospital Dublin (Ireland), University of Verona (Italy), CLPP Vaccines Network (Portugal), University of Medicine and Pharmacy ‘Iuliu Hatieganu’ Cluj-Napoca (Romania), SLOVACRIN Pavol Jozef Šafárik University in Košice Faculty of Medicine (Slovakia), Institut Universitari d’Investigació en Atenció Primària Jordi Gol (Spain), Teamit Institute, Barcelona Health Hub (Spain)
|
|
Study start
|
December 2021 |
|
Funder(s) |
European Medicines Agency |
|
Study design |
Observational study |
|
External links |
Description of the study protocol of the European study available at:
http://www.encepp.eu/encepp/viewResource.htm?id=40288
Website to participate in the study for pregnant and lactating women vaccinated in the last 48 hours:
www.covidvaccinemonitor.eu/ch |
|